Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
RM

Robert Maxey — 9 Patents

Merck: 7 patents #1,614 of 9,382Top 20%
Genentech: 1 patents #1,597 of 2,392Top 70%
MDMerk Sharp & Dohme: 1 patents #1 of 28Top 4%
Harlow, GB: #47 of 388 inventorsTop 15%
Overall (All Time): #535,341 of 4,157,543Top 15%
9 Patents All Time
Robert Maxey has been granted 9 US patents while listed as an inventor at Merck. The first was granted in 2001 and the most recent in May 2018. Robert Maxey ranks #535,341 of 4,157,543 US inventors in our database (top 12.9%). Patent records list Robert Maxey in Harlow, GB.

Patents per Year

Patents granted per year, 2001 to 2018Bar chart with a peak of 3 patents in 2006.peak 32001: 1 patents20012004: 1 patents20042005: 1 patents20052006: 3 patents20062007: 1 patents20072009: 1 patents20092018: 1 patents2018

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
9981916 Pyridazine derivatives as RORc modulators Monique Bodil van Niel, Andrew Peter Cridland, Benjamin Fauber, Alberto Gobbi, Christopher Hurley +3 more 2018-05-29
7592456 Arylsulfonylnaphthalene derivatives as 5HT2A antagonists Mark Stuart Chambers, Neil Roy Curtis, Emanuela Gancia, Myra Gilligan, Alexander Humphries +2 more 2009-09-22 $80,717,000
7176203 Imidazo-triazine derivatives as ligands for gaba receptors Mark Stuart Chambers, Simon Charles Goodacre, David Hallett, Michael Geoffrey Neil Russell, Leslie Joseph Street 2007-02-13 $62,407,000
7144887 Substituted 1,2,3-triazolo[1,5-a]quinazolines for enhancing cognition Helen Jane Bryant, Mark Stuart Chambers, Philip Jones, Angus Murray MacLeod 2006-12-05 $64,547,000
7094777 5-HT2A receptor ligands Mark Stuart Chambers, Neil Roy Curtis, Angus Murray MacLeod, Helen Jane Szekeres 2006-08-22 $88,681,000
7030128 Imidazo-pyrimidine derivatives as ligands for GABA receptors Wesley Blackaby, Jose Luis Castro Pineiro, Mark Stuart Chambers, Simon Charles Goodacre, David Hallett +5 more 2006-04-18 $34,279,000
6900209 Nitrogen substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives for enhancing cognition Mark Stuart Chambers, Philip Jones, Angus Murray MacLeod, Helen Jane Szekeres 2005-05-31 $131,524,000
6730681 Triazolo-pyrimidine derivatives as ligands for gaba receptors Mark Stuart Chambers, Ian Collins, Simon Charles Goodacre, David Hallett, Philip Jones +2 more 2004-05-04 $88,786,000
6316468 Phenylindole derivatives as 5-HT2A receptor antagonists Michael Rowley, Monique Bodil Van Niel 2001-11-13 $75,882,000